Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001415889-25-011957·Jade Biosciences, Inc.
Schedule 13G ownership disclosure
Jade Biosciences Inc
Common Stock, $0.0001 par value · CUSIP: 008064206
Event date: 2025-04-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners III, L.P.
Shares: 3,220,369.00 · Class: 9.9%
- VHCP Co-Investment Holdings III, LLC
Shares: 3,220,369.00 · Class: 9.9%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 3,220,369.00 · Class: 9.9%
- VHCP Management III, LLC
Shares: 3,220,369.00 · Class: 9.9%
- VHCP Management EG, LLC
Shares: 3,220,369.00 · Class: 9.9%
- Nimish Shah
Shares: 3,220,369.00 · Class: 9.9%
- Bong Y Koh
Shares: 3,220,369.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-011957
- Form type
- SCHEDULE 13G
- Filer
- Jade Biosciences, Inc.
- CIK
- CIK 1798749
- Filed
- May 05, 2025
- Reporting period
- Apr 28, 2025
- Description
- Schedule 13G beneficial ownership